Regular Versus As-Needed Short-Acting Inhaled β -Agonist Therapy for Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regular Versus As-Needed Short-Acting Inhaled β -Agonist Therapy for Chronic Obstructive Pulmonary Disease

Published:2001-01 Issue:1 Volume:163 Page:85-90
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

COOK DEBORAH,GUYATT GORDON,WONG ERIC,GOLDSTEIN ROGER,BEDARD MICHEL,AUSTIN PEGGY,RAMSDALE HELEN,JAESCHKE ROMAN,SEARS MALCOLM

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference28 articles.

1. International Comparisons in COPD Mortality

2. A Comparison of the Bronchodilating Effects of a Beta-2 Adrenergic Agent (Albuterol) and an Anticholinergic Agent (Ipratropium Bromide), Given by Aerosol Alone or in Sequence

3. Prognosis in Chronic Obstructive Pulmonary Disease1–3

4. Efficacy of Inhaled Metaproterenol and Orally-administered Theophylline in Patients with Chronic Airflow Obstruction

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations;Journal of the Formosan Medical Association;2021-10

2. Comparison of the rapid effects of single inhalations of formoterol and tiotropium bromide on respiratory function and COPD symptoms in a randomized crossover study;Respiratory Investigation;2017-11

3. Chronic obstructive pulmonary disease: A guide for the primary care physician;Disease-a-Month;2016-06

4. An update on pharmacologic management of chronic obstructive pulmonary disease;Current Opinion in Pulmonary Medicine;2016-03

5. Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease;BMC Pulmonary Medicine;2015-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3